Yoga Guru Baba Ramdev’s Patanjali has launched its medicine for COVID-19. The medicine, being called Coronil, has been launched on Tuesday. Patanjali Ayurved Limited MD Acharya Balkrishna had announced the launch on Twitter on Monday evening.
During the launch, Patanjali co-founder Baba Ramdev said that their clinical trial found that 69% of the patients tested recovered from COVID-19 within three days, while 100% of the patients recovered within a week, as per news agency ANI.
In his post, Acharya Balkrishna had announced that it is the first and foremost evidence-based ayurvedic medicine against the coronavirus contagion. The medicine has been manufactured by Haridwar’s Divya Pharmacy and Patanjali Ayurved Limited in Haridwar, based on a joint research by Patanjali Research Institute in Haridwar and the National Institute of Medical Science, Jaipur.
In a press release, Patanjali also said that it would disclose the results of the randomised clinical trials conducted on COVID-19 patients while controlling the placebo. The trial was conducted by Patanjali Ayurvedic Medicines. The disclosure would be made by co-founders Baba Ramdev and Acharya Balkrishna, while the scientists, doctors and researchers involved in the trial would also be present. The event would be held at the Patanjali Yogpeeth in Haridwar.
Earlier this month, ANI had quoted Acharya Balkrishna as saying that they had first conducted a simulation after which compounds that could fight the novel coronavirus were identified. He further said that they then conducted clinical trials on several patients who had tested positive for COVID-19 and the results were favourable. He had further said, according to ANI, that after taking their medicine, the patients recovered within five to 14 days, after which they tested negative for the disease.
– With inputs from Agencies